Previous studies demonstrated that resveratrol alleviated alcoholic fatty liver disease in mice by increasing hepatic AdipoR1/R2 expression [13] and attenuated DN by increasing renal AdipoR1 expression in rats with streptozotocin-induced diabetes [14]. This evidence concerns the gene ADIPOR1 and alcoholic fatty liver disease.